speb/financial-data huggingface dataset:
Financial ratios for BKHT.DE — annual report dated 2025-12-31
Total revenue: 35631764.705882356
Gross profit: 27072941.17647059
Operating income: -27616470.588235296
Net income: -24409411.76470588
Capital expenditures: 50588.23529411765
Operating cash flow: -8952941.176470589
Depreciation & amortization: 11621176.470588235
Net tangible assets: 129520000
Owner earnings: -12838823.529411765
Return on net tangible assets (%): -9.912618537223414
Buffett classification: The Gruesome
Stock price: 18.764705882352942
Shares outstanding: 10447666
Book value: 238777647.05882353
P/B ratio: 0.8210457807164924
Market cap (USD): 196047379.64705884
Debt to equity: 0.12113657303619907
Current ratio: 1.4131215616579387
Quick ratio: 1.3914152525069523
Interest coverage ratio: -14.744974874371861
COGS to revenue (%): 24.020206689338657
SG&A to revenue (%): 29.411958926271996
Free cash flow (dilution-adjusted): -12349411.764705883
Buyback yield (%): 0
Retained earnings: 65882.35294117648
Inventory turnover: 0.963831478537361
Receivables turnover: 7.124676546694896
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.892504153016622
FCF margin (%): -34.658434311750916
Revenue growth (%): 7.669166250069441
Rule of 40 score: -26.989268061681475
Financial ratios for BMA.OL — annual report dated 2021-12-31
Operating income: 26159659.09090909
Net income: 20038750
Capital expenditures: 0
Owner earnings: 20038750
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.8825541619156216
P/E ratio: 10.043435093081841
Shares outstanding: 69819290
Market cap (USD): 201257884.97149375
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMA.OL — annual report dated 2022-12-31
Total revenue: 253865890.6882591
Gross profit: 119527834.00809716
Operating income: 14282085.020242915
Net income: 43499392.7125506
Capital expenditures: 11402530.36437247
Operating cash flow: 31880465.587044533
Depreciation & amortization: 8303340.080971659
Net tangible assets: 106994230.76923077
Owner earnings: 40400202.42914979
Return on net tangible assets (%): 37.75923443600103
Capex to operating income (%): 79.83799528017745
Buffett classification: The Gruesome
Stock price: 2.823886639676113
P/E ratio: 4.532517534797359
Shares outstanding: 69819290
Book value: 109080161.94331986
P/B ratio: 1.8074942016048807
Market cap (USD): 197161760.22267202
Debt to equity: 1.3570007571596119
Current ratio: 0.8471106368355369
Quick ratio: 0.49826819077935935
Effective tax rate (%): 18.81206822616873
Interest coverage ratio: 3.548254878294106
COGS to revenue (%): 52.916938276330185
SG&A to revenue (%): 5.029632863473534
Free cash flow (dilution-adjusted): 18670546.55870445
Buyback yield (%): 0
Retained earnings: 104397570.85020243
Inventory turnover: 3.440788296871233
Receivables turnover: 7.671447184907877
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.550831185423428
FCF margin (%): 7.35449197530495
Rule of 40 score: 7.35449197530495
Financial ratios for BMA.OL — annual report dated 2023-12-31
Total revenue: 219146954.81335953
Gross profit: 111622003.92927308
Operating income: 7795776.031434185
Net income: 5991944.990176817
Capital expenditures: 5102455.7956778
Operating cash flow: 20994007.85854617
Depreciation & amortization: 11715520.628683694
Net tangible assets: 108903339.88212182
Owner earnings: 12605009.823182713
Return on net tangible assets (%): 11.57449334136723
Capex to operating income (%): 65.45154420937236
Buffett classification: The Good
Stock price: 1.905697445972495
P/E ratio: 22.205551427915665
Shares outstanding: 69819290
Book value: 110911493.12377208
P/B ratio: 1.1996452205735826
Market cap (USD): 133054442.63261296
Debt to equity: 1.2743793835506643
Current ratio: 0.7460358292845155
Quick ratio: 0.438024676131283
Effective tax rate (%): -94.61442746386753
Interest coverage ratio: 0.8257223418755397
COGS to revenue (%): 49.06522701885683
SG&A to revenue (%): 5.712765518737595
Free cash flow (dilution-adjusted): 15427210.21611002
Buyback yield (%): 0
Retained earnings: 107312966.60117878
Inventory turnover: 3.1307944225956383
Receivables turnover: 5.927375622716705
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.769305812428104
FCF margin (%): 7.039664424837152
Revenue growth (%): -13.676093224171476
Rule of 40 score: -6.636428799334324
Financial ratios for BMA.OL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.612595419847328
Shares outstanding: 69819290
Market cap (USD): 112590267.27099235
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMA.OL — quarterly report dated 2024-12-31
Operating income: -1270962.0476610768
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.3756613756613756
Shares outstanding: 69819290
Market cap (USD): 96047700.52910052
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMA.OL — annual report dated 2024-12-31
Total revenue: 191833009.70873785
Gross profit: 98203177.40511915
Operating income: 7252603.706972639
Net income: -22822506.619593997
Capital expenditures: 3114827.890556046
Operating cash flow: 5030361.87113857
Depreciation & amortization: 7751103.265666372
Net tangible assets: 78953221.53574581
Owner earnings: -18186231.24448367
Return on net tangible assets (%): -23.03418516779573
Capex to operating income (%): 42.94771941780655
Buffett classification: The Good
Stock price: 1.3756613756613756
Shares outstanding: 69819290
Book value: 80539187.99646956
P/B ratio: 1.1925585906491978
Market cap (USD): 96047700.52910052
Debt to equity: 1.5531189281420785
Current ratio: 0.752134476608297
Quick ratio: 0.4025992817393367
Interest coverage ratio: 0.8251360633020706
COGS to revenue (%): 48.80798797129749
SG&A to revenue (%): 5.7156121001091345
Free cash flow (dilution-adjusted): 1751632.8331862313
Buyback yield (%): 0
Retained earnings: 73596116.50485437
Inventory turnover: 2.927603745518873
Receivables turnover: 6.058008339465293
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.382202833936847
FCF margin (%): 0.9131029304319181
Revenue growth (%): -12.463757540178506
Rule of 40 score: -11.550654609746587
Financial ratios for BMA.OL — quarterly report dated 2025-03-31
Total revenue: 60687022.900763355
Gross profit: 28043893.12977099
Operating income: 4312977.099236641
Net income: 9045801.526717557
Capital expenditures: 1937022.9007633587
Operating cash flow: -877862.5954198473
Depreciation & amortization: 2099236.641221374
Net tangible assets: 91908396.94656488
Owner earnings: 9208015.267175572
Return on net tangible assets (%): 10.018687707641195
Capex to operating income (%): 44.911504424778755
Buffett classification: The Good
Stock price: 1.545801526717557
P/E ratio: 2.9827861234177213
Shares outstanding: 69819290
Book value: 93559160.30534354
P/B ratio: 1.1535670555838853
Market cap (USD): 107926765.07633586
Debt to equity: 1.4842427332993366
Current ratio: 0.7770326136885622
Quick ratio: 0.4355535140101056
Effective tax rate (%): 3.7563451776649743
Interest coverage ratio: 1.8373983739837398
COGS to revenue (%): 53.789308176100626
SG&A to revenue (%): 3.30188679245283
Free cash flow (dilution-adjusted): -2843511.4503816795
Buyback yield (%): 0
Retained earnings: 88578244.27480915
Inventory turnover: 0.9203658864675813
Receivables turnover: 1.4732453092425297
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3184242921624945
FCF margin (%): -4.685534591194969
Rule of 40 score: -4.685534591194969
Financial ratios for BMA.OL — quarterly report dated 2025-06-30
Total revenue: 615690.1688182721
Gross profit: -30933465.73982125
Operating income: -56981132.0754717
Net income: 2194637.5372393248
Capital expenditures: 1668321.7477656405
Operating cash flow: -99304.86593843099
Depreciation & amortization: 2184707.050645482
Net tangible assets: 101102284.01191658
Owner earnings: 2711022.8401191654
Return on net tangible assets (%): 2.681465474904233
Buffett classification: The Gruesome
Stock price: 1.717974180734856
P/E ratio: 10.671090057492389
Shares outstanding: 69819290
Book value: 102730883.81330687
P/B ratio: 1.1675917999033347
Market cap (USD): 119947737.53723933
Debt to equity: 1.418366360560657
Current ratio: 0.7776786510839504
Quick ratio: 0.40645909536979213
Effective tax rate (%): 8.298755186721992
Interest coverage ratio: -23.13709677419355
COGS to revenue (%): 5124.193548387097
SG&A to revenue (%): 282.258064516129
Free cash flow (dilution-adjusted): -1787487.5868917576
Buyback yield (%): 0
Retained earnings: 94349553.12810327
Inventory turnover: 0.763518385003605
Receivables turnover: 0.01504489201650085
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -28.82837620578778
FCF margin (%): -290.3225806451613
Revenue growth (%): -98.9854665142743
Rule of 40 score: -389.30804715943555
Financial ratios for BMA.OL — quarterly report dated 2025-09-30
Total revenue: 53887775.5511022
Gross profit: 24609218.436873745
Operating income: 3927855.7114228457
Net income: 5991983.967935871
Capital expenditures: 2114228.4569138275
Operating cash flow: 2905811.623246493
Depreciation & amortization: 2204408.8176352703
Net tangible assets: 106983967.93587174
Owner earnings: 6082164.328657314
Return on net tangible assets (%): 5.6851175423808185
Capex to operating income (%): 53.826530612244895
Buffett classification: The Good
Stock price: 1.6332665330661322
P/E ratio: 6.61738105595437
Shares outstanding: 69819290
Book value: 108527054.10821643
P/B ratio: 1.0507380915889575
Market cap (USD): 114033509.71943888
Debt to equity: 1.349275228510756
Current ratio: 0.7777777777777778
Quick ratio: 0.393030794165316
Effective tax rate (%): 10.612855007473843
Interest coverage ratio: 1.6065573770491803
COGS to revenue (%): 54.33246560059503
SG&A to revenue (%): 3.495723317218297
Free cash flow (dilution-adjusted): 771543.0861723446
Buyback yield (%): 0
Retained earnings: 100891783.56713426
Inventory turnover: 0.6838286917856307
Receivables turnover: 1.4012506513809275
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9338924518993588
FCF margin (%): 1.4317590182223874
Revenue growth (%): 8652.417738703212
Rule of 40 score: 8653.849497721434
Financial ratios for BMA.OL — annual report dated 2025-12-31
Total revenue: 234408557.21393034
Gross profit: 116127363.18407959
Operating income: 9549552.23880597
Net income: 10774029.850746268
Capital expenditures: 8647363.1840796
Operating cash flow: 24303383.084577113
Depreciation & amortization: 8624676.616915422
Net tangible assets: 100327860.69651741
Owner earnings: 10751343.28358209
Return on net tangible assets (%): 10.716209045963732
Capex to operating income (%): 90.5525512383691
Buffett classification: The Gruesome
Stock price: 1.4641434262948207
P/E ratio: 9.488135442189352
Shares outstanding: 69819290
Book value: 101836417.91044778
P/B ratio: 1.0038202106830392
Market cap (USD): 102225454.48207171
Debt to equity: 1.2606169683894566
Current ratio: 0.6777814549831759
Quick ratio: 0.2675400087487328
Effective tax rate (%): 7.667709834485935
Interest coverage ratio: 1.0011683583521975
COGS to revenue (%): 50.459418135449184
SG&A to revenue (%): 5.59108008044805
Free cash flow (dilution-adjusted): 15523084.577114427
Buyback yield (%): 0
Retained earnings: 93743582.08955224
Inventory turnover: 3.025125270071841
Receivables turnover: 11.471647212929552
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.899673926860983
FCF margin (%): 6.622234598264883
Revenue growth (%): 22.194067418238085
Rule of 40 score: 28.816302016502966
Financial ratios for BMA.OL — quarterly report dated 2025-12-31
Total revenue: 58676616.91542288
Gross profit: 35452736.31840796
Operating income: 955223.8805970149
Net income: -6487562.189054726
Capital expenditures: 2856318.407960199
Operating cash flow: 22432736.31840796
Depreciation & amortization: 2059701.4925373134
Net tangible assets: 100327860.69651741
Owner earnings: -7284179.104477611
Return on net tangible assets (%): -7.260375187817057
Capex to operating income (%): 299.0208333333333
Buffett classification: The Gruesome
Stock price: 1.4641434262948207
P/E ratio: 9.513892825351009
Shares outstanding: 69819290
Book value: 101836417.91044778
P/B ratio: 1.0038202106830392
Market cap (USD): 102225454.48207171
Debt to equity: 1.2606169683894566
Current ratio: 0.6777814549831759
Quick ratio: 0.2675400087487328
Interest coverage ratio: 0.46153846153846156
COGS to revenue (%): 39.579447176530444
SG&A to revenue (%): 15.77073088010853
Free cash flow (dilution-adjusted): 19513134.328358207
Buyback yield (%): 0
Retained earnings: 93743582.08955224
Inventory turnover: 0.5939671867484749
Receivables turnover: 2.8715566398356045
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.4901052347833811
FCF margin (%): 33.25538409360692
Revenue growth (%): 8.886693346210562
Rule of 40 score: 42.142077439817484
Financial ratios for BTLS.BR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.090909090909092
Shares outstanding: 45444456
Market cap (USD): 367686962.18181825
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BTLS.BR — annual report dated 2022-12-31
Total revenue: 0
Operating income: -23968085.10638298
Net income: -24181914.893617023
Capital expenditures: 752127.6595744682
Operating cash flow: -21373404.25531915
Depreciation & amortization: 1676595.7446808512
Net tangible assets: 39911702.127659574
Owner earnings: -23257446.80851064
Return on net tangible assets (%): -58.27224991337261
Buffett classification: The Gruesome
Stock price: 7.23404255319149
Shares outstanding: 45444456
Book value: 40546808.510638304
P/B ratio: 8.10784228367529
Market cap (USD): 328747128.5106383
Debt to equity: 0.17056724563152648
Current ratio: 6.335906040268457
Quick ratio: 6.335906040268457
Interest coverage ratio: -91.21457489878543
Free cash flow (dilution-adjusted): -23969148.936170217
Buyback yield (%): 0
Retained earnings: -20915957.446808513
Capitalized R&D asset: 20013829.78723404
ROCI (R&D-adjusted, %): -16.014109347442684
Rule of 40 score: 0
Financial ratios for BTLS.BR — annual report dated 2023-12-31
Total revenue: 0
Operating income: -23212222.22222222
Net income: -22788888.888888888
Capital expenditures: 346666.6666666667
Operating cash flow: -20314444.444444444
Depreciation & amortization: 1982222.2222222222
Net tangible assets: 27696666.666666664
Owner earnings: -21153333.333333332
Return on net tangible assets (%): -76.37501504392827
Buffett classification: The Gruesome
Stock price: 5.188888888888889
Shares outstanding: 45444456
Book value: 28410000
P/B ratio: 8.300113790918692
Market cap (USD): 235806232.8
Debt to equity: 0.2375141773241034
Current ratio: 4.491525423728813
Quick ratio: 4.491525423728813
Interest coverage ratio: -129.75776397515529
Free cash flow (dilution-adjusted): -21972222.222222224
Buyback yield (%): 0
Retained earnings: -44666666.666666664
Capitalized R&D asset: 31862599.290780142
ROCI (R&D-adjusted, %): -26.498960022857098
Rule of 40 score: 0
Financial ratios for BTLS.BR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 28157291.666666668
Buffett classification: The Gruesome
Stock price: 3.4166666666666665
Shares outstanding: 45444456
Book value: 28755208.333333332
P/B ratio: 5.399667295055244
Market cap (USD): 155268558
Debt to equity: 0.17562035863068284
Current ratio: 5.504510174113699
Quick ratio: 5.504510174113699
Buyback yield (%): 0
Retained earnings: -12211458.333333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BTLS.BR — annual report dated 2024-12-31
Total revenue: 0
Operating income: -14054166.666666668
Net income: -13737500
Capital expenditures: 111458.33333333334
Operating cash flow: -13178125
Depreciation & amortization: 1904166.6666666667
Net tangible assets: 28157291.666666668
Owner earnings: -11944791.666666668
Return on net tangible assets (%): -42.421664015389744
Buffett classification: The Gruesome
Stock price: 3.4166666666666665
Shares outstanding: 45444456
Book value: 28755208.333333332
P/B ratio: 5.399667295055244
Market cap (USD): 155268558
Debt to equity: 0.17562035863068284
Current ratio: 5.504510174113699
Quick ratio: 5.504510174113699
Interest coverage ratio: -85.93630573248407
Free cash flow (dilution-adjusted): -14007291.666666666
Buyback yield (%): 0
Retained earnings: -12211458.333333334
Capitalized R&D asset: 30383922.163120568
ROCI (R&D-adjusted, %): -30.24681301175287
Rule of 40 score: 0
Financial ratios for BTLS.BR — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 22661176.470588237
Buffett classification: The Gruesome
Stock price: 5.6117647058823525
Shares outstanding: 45444456
Book value: 23305882.352941178
P/B ratio: 10.942456088844017
Market cap (USD): 255023594.2588235
Debt to equity: 0.21665825340737
Current ratio: 3.6112580279561763
Quick ratio: 3.6112580279561763
Buyback yield (%): 0
Retained earnings: -23385882.352941178
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for C1V0.DE — annual report dated 2021-12-31
Total revenue: 16948863.636363637
Gross profit: 10921590.909090908
Operating income: -447727.2727272727
Net income: -1288636.3636363635
Capital expenditures: 26136.363636363636
Operating cash flow: -817045.4545454546
Depreciation & amortization: 887500
Net tangible assets: 3348863.6363636362
Owner earnings: -427272.7272727272
Return on net tangible assets (%): -12.758737699355274
Buffett classification: The Gruesome
Stock price: 18.409090909090907
Shares outstanding: 2128362
Book value: 6323863.636363635
P/B ratio: 6.195770781671159
Market cap (USD): 39181209.54545454
Debt to equity: 1.6844564240790658
Current ratio: 5.658488063660477
Quick ratio: 5.655835543766578
Interest coverage ratio: -0.5502793296089385
COGS to revenue (%): 35.56151525310091
SG&A to revenue (%): 2.172980221253771
Free cash flow (dilution-adjusted): -843181.8181818182
Buyback yield (%): 0.2523241051273407
Retained earnings: -22286363.636363637
Inventory turnover: 1326.0000000000002
Receivables turnover: 3.4565469293163384
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.625441460651696
FCF margin (%): -4.974857525980557
Rule of 40 score: -4.974857525980557
Financial ratios for C1V0.DE — annual report dated 2022-12-31
Total revenue: 16642553.191489363
Gross profit: 10651063.829787234
Operating income: -955319.1489361703
Net income: -2370212.765957447
Capital expenditures: 72340.4255319149
Operating cash flow: 3236170.2127659577
Depreciation & amortization: 1443617.0212765958
Net tangible assets: 1338297.8723404256
Owner earnings: -998936.1702127659
Return on net tangible assets (%): -74.6422893481717
Buffett classification: The Gruesome
Stock price: 9.063829787234043
Shares outstanding: 2128362
Book value: 3657446.808510639
P/B ratio: 5.2744747643979055
Market cap (USD): 19291110.893617023
Debt to equity: 1.9043048283885977
Current ratio: 1.6645815358067297
Quick ratio: 1.6617773943054355
Interest coverage ratio: -2.3693931398416885
COGS to revenue (%): 36.001022756328304
Free cash flow (dilution-adjusted): 3162765.9574468085
Buyback yield (%): 0
Retained earnings: -23232978.72340426
Inventory turnover: 433.2307692307692
Receivables turnover: 4.655952380952381
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.826420287006096
FCF margin (%): 19.004091025313215
Revenue growth (%): -1.8072624303678226
Rule of 40 score: 17.196828594945394
Financial ratios for C1V0.DE — annual report dated 2023-12-31
Total revenue: 15760000
Gross profit: 9991111.11111111
Operating income: -2244444.4444444445
Net income: -3804444.4444444445
Capital expenditures: 14444.444444444443
Operating cash flow: 397777.77777777775
Depreciation & amortization: 3492222.222222222
Net tangible assets: -2762902.222222222
Owner earnings: -326666.6666666669
Buffett classification: The Gruesome
Stock price: 8.055555555555555
Shares outstanding: 2128362
Book value: 0
Market cap (USD): 17145138.333333332
Current ratio: 0.39651416122004357
Quick ratio: 0.39457758412006777
Interest coverage ratio: -5.315789473684211
COGS to revenue (%): 36.60462492949802
Free cash flow (dilution-adjusted): 382222.2222222222
Buyback yield (%): 0
Retained earnings: -29206666.666666664
Inventory turnover: 649
Receivables turnover: 15.90134529147982
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -43.403523850451236
FCF margin (%): 2.42526790750141
Revenue growth (%): -5.302991562260299
Rule of 40 score: -2.8777236547588894
Financial ratios for C1V0.DE — annual report dated 2024-12-31
Total revenue: 4651070.458333333
Gross profit: 12612.968750000002
Operating income: -2658925.4062500005
Net income: -3863158.7812500005
Capital expenditures: 0
Operating cash flow: -30208.333333333336
Depreciation & amortization: 1940625
Net tangible assets: 8596450.15625
Owner earnings: -1922533.7812500005
Return on net tangible assets (%): -22.364275326510597
Buffett classification: The Gruesome
Stock price: 3.395833333333333
Shares outstanding: 2128362
Book value: 8596456.406250002
P/B ratio: 0.8407606906195958
Market cap (USD): 7227562.624999999
Debt to equity: 0.7558303514390797
Current ratio: 0.7101219934583065
Quick ratio: 0.7094755104637401
Interest coverage ratio: -6.84655136980735
COGS to revenue (%): 99.72881578847294
Free cash flow (dilution-adjusted): -30208.333333333336
Buyback yield (%): 0
Retained earnings: -30178583.46875
Inventory turnover: 1113.2297975000001
Receivables turnover: 1.0574145551452294
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.326902067397576
FCF margin (%): -0.6494920600312343
Revenue growth (%): -70.48813160956009
Rule of 40 score: -71.13762366959132
Financial ratios for C1V0.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 8596450.15625
Buffett classification: The Gruesome
Stock price: 3.395833333333333
Shares outstanding: 2128362
Book value: 8596456.406250002
P/B ratio: 0.8407606906195958
Market cap (USD): 7227562.624999999
Debt to equity: 0.7558303514390797
Current ratio: 0.7101219934583065
Quick ratio: 0.7094755104637401
Buyback yield (%): 0
Retained earnings: -30178583.46875
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for C1V0.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.176470588235294
Shares outstanding: 2128362
Market cap (USD): 13145765.294117648
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCBG — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.73
Shares outstanding: 17101409
Market cap (USD): 405816435.57
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCBG — annual report dated 2022-12-31
Total revenue: 193669000
Net income: 33412000
Capital expenditures: 6322000
Operating cash flow: 92692000
Depreciation & amortization: 7756000
Net tangible assets: 302945000
Owner earnings: 34846000
Return on net tangible assets (%): 11.502417930647477
Buffett classification: The Gruesome
Stock price: 29.86
P/E ratio: 15.283373420926612
Shares outstanding: 17101409
Book value: 396038000
P/B ratio: 1.2893916057045032
Market cap (USD): 510648072.74
Debt to equity: 0.26161883455627993
Effective tax rate (%): 18.984783931832013
COGS to revenue (%): 0
SG&A to revenue (%): 49.78287697050121
Free cash flow (dilution-adjusted): 84740000
Buyback yield (%): 0
Retained earnings: 387009000
Capitalized R&D asset: 0
FCF margin (%): 43.75506663430905
Rule of 40 score: 43.75506663430905
Financial ratios for CCBG — annual report dated 2023-12-31
Total revenue: 223614000
Net income: 52258000
Capital expenditures: 7046000
Operating cash flow: 54782000
Depreciation & amortization: 8078000
Net tangible assets: 355099000
Owner earnings: 53290000
Return on net tangible assets (%): 15.007082531913635
Buffett classification: The Gruesome
Stock price: 27.73
P/E ratio: 9.074631091316162
Shares outstanding: 17101409
Book value: 448032000
P/B ratio: 1.058455805768338
Market cap (USD): 474222071.57
Debt to equity: 0.1374589315048925
Effective tax rate (%): 20.419348272028312
COGS to revenue (%): 0
SG&A to revenue (%): 44.738254313236204
Free cash flow (dilution-adjusted): 46499000
Buyback yield (%): 0.7823338942696947
Retained earnings: 426275000
Capitalized R&D asset: 0
FCF margin (%): 20.79431520387811
Revenue growth (%): 15.461947962761204
Rule of 40 score: 36.256263166639314
Financial ratios for CCBG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 33.99
Shares outstanding: 17101409
Market cap (USD): 581276891.9100001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCBG — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 35.51
Shares outstanding: 17101409
Market cap (USD): 607271033.5899999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCBG — annual report dated 2024-12-31
Total revenue: 226503000
Net income: 52915000
Capital expenditures: 8688000
Operating cash flow: 63573000
Depreciation & amortization: 7831000
Net tangible assets: 402544000
Owner earnings: 52058000
Return on net tangible assets (%): 12.932250884375375
Buffett classification: The Gruesome
Stock price: 35.51
P/E ratio: 11.476349496173107
Shares outstanding: 17101409
Book value: 495317000
P/B ratio: 1.2260250174938474
Market cap (USD): 607271033.5899999
Debt to equity: 0.11254408792752923
Effective tax rate (%): 21.235968765251343
COGS to revenue (%): 0
SG&A to revenue (%): 46.48680149931789
Free cash flow (dilution-adjusted): 53083000
Buyback yield (%): 0.38368370482381736
Retained earnings: 463949000
Capitalized R&D asset: 0
FCF margin (%): 23.43589268133314
Revenue growth (%): 1.2919584641390969
Rule of 40 score: 24.727851145472236
Financial ratios for CCBG — quarterly report dated 2025-03-31
Total revenue: 58985000
Net income: 16858000
Capital expenditures: 2382000
Operating cash flow: 21867000
Depreciation & amortization: 1850000
Net tangible assets: 419842000
Owner earnings: 16326000
Return on net tangible assets (%): 3.8886057135779653
Buffett classification: The Gruesome
Stock price: 35.07
P/E ratio: 8.894092027968917
Shares outstanding: 17101409
Book value: 512575000
P/B ratio: 1.1700656755206555
Market cap (USD): 599746413.63
Debt to equity: 0.17730283373164904
Effective tax rate (%): 23.320445758471685
COGS to revenue (%): 0
SG&A to revenue (%): 45.68110536577096
Free cash flow (dilution-adjusted): 19086000
Buyback yield (%): 0
Retained earnings: 476715000
Capitalized R&D asset: 0
FCF margin (%): 32.357378994659655
Rule of 40 score: 32.357378994659655
Financial ratios for CCBG — quarterly report dated 2025-06-30
Total revenue: 60707000
Net income: 15044000
Capital expenditures: 1840000
Operating cash flow: 32624000
Depreciation & amortization: 1906000
Net tangible assets: 433730000
Owner earnings: 15110000
Return on net tangible assets (%): 3.4837341203052588
Buffett classification: The Gruesome
Stock price: 38.63
P/E ratio: 20.708025505297474
Shares outstanding: 17101409
Book value: 526423000
P/B ratio: 1.2549364858108405
Market cap (USD): 660627429.6700001
Debt to equity: 0.14779559403749457
Effective tax rate (%): 24.930139720558884
COGS to revenue (%): 0
SG&A to revenue (%): 44.76584248933401
Free cash flow (dilution-adjusted): 30258000
Buyback yield (%): 0
Retained earnings: 487665000
Capitalized R&D asset: 0
FCF margin (%): 49.84268700479352
Revenue growth (%): 2.9193862846486396
Rule of 40 score: 52.76207328944216
Financial ratios for CCBG — quarterly report dated 2025-09-30
Total revenue: 63413000
Net income: 15950000
Capital expenditures: 1745000
Operating cash flow: 21563000
Depreciation & amortization: 1899000
Net tangible assets: 451540000
Owner earnings: 16104000
Return on net tangible assets (%): 3.566461443061523
Buffett classification: The Gruesome
Stock price: 41.27
P/E ratio: 14.749125416492518
Shares outstanding: 17101409
Book value: 540635000
P/B ratio: 1.3054558980273199
Market cap (USD): 705775149.4300001
Debt to equity: 0.15445910827082968
Effective tax rate (%): 24.37532596842255
COGS to revenue (%): 0
SG&A to revenue (%): 42.01977512497437
Free cash flow (dilution-adjusted): 19370000
Buyback yield (%): 0
Retained earnings: 499176000
Capitalized R&D asset: 0
FCF margin (%): 30.545787141437874
Revenue growth (%): 4.45747607359942
Rule of 40 score: 35.00326321503729
Financial ratios for CCBG — quarterly report dated 2025-12-31
Total revenue: 61317000
Net income: 13705000
Capital expenditures: 1622000
Operating cash flow: 11560000
Depreciation & amortization: 1861000
Net tangible assets: 463756000
Owner earnings: 13944000
Return on net tangible assets (%): 3.0067535514365313
Buffett classification: The Gruesome
Stock price: 42.3
P/E ratio: 11.751540859691017
Shares outstanding: 17101409
Book value: 552851000
P/B ratio: 1.308471180661697
Market cap (USD): 723389600.6999999
Debt to equity: 0.1290329582473397
Effective tax rate (%): 26.321165528735012
COGS to revenue (%): 0
SG&A to revenue (%): 44.93044343330561
Free cash flow (dilution-adjusted): 8987000
Buyback yield (%): 0
Retained earnings: 508443000
Capitalized R&D asset: 0
FCF margin (%): 14.656620513071417
Revenue growth (%): -3.305315944680113
Rule of 40 score: 11.351304568391303
Financial ratios for CCBG — annual report dated 2025-12-31
Total revenue: 244423000
Net income: 61557000
Capital expenditures: 7589000
Operating cash flow: 87614000
Depreciation & amortization: 7516000
Net tangible assets: 463756000
Owner earnings: 61484000
Return on net tangible assets (%): 13.257833860909615
Buffett classification: The Gruesome
Stock price: 42.3
P/E ratio: 11.751540859691017
Shares outstanding: 17101409
Book value: 552851000
P/B ratio: 1.308471180661697
Market cap (USD): 723389600.6999999
Debt to equity: 0.1290329582473397
Effective tax rate (%): 24.670509196372848
COGS to revenue (%): 0
SG&A to revenue (%): 44.31538766809997
Free cash flow (dilution-adjusted): 77701000
Buyback yield (%): 0
Retained earnings: 508443000
Capitalized R&D asset: 0
FCF margin (%): 31.78956153880772
Revenue growth (%): 7.911594989911834
Rule of 40 score: 39.70115652871956
Financial ratios for CIM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.02
Shares outstanding: 83646018
Market cap (USD): 2176469388.36
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIM — annual report dated 2022-12-31
Total revenue: -415210000
Net income: -513066000
Capital expenditures: 0
Operating cash flow: 325722000
Depreciation & amortization: 0
Net tangible assets: 2666803000
Owner earnings: -513066000
Return on net tangible assets (%): -19.23899140656434
Buffett classification: The Gruesome
Stock price: 10.94
Shares outstanding: 83646018
Book value: 2666803000
P/B ratio: 0.34314024579993346
Market cap (USD): 915087436.92
Debt to equity: 3.980064894182285
Free cash flow (dilution-adjusted): 317545000
Buyback yield (%): 5.3422217405301105
Retained earnings: -1883620000
Receivables turnover: -6.722089107628546
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIM — annual report dated 2023-12-31
Total revenue: 204768000
Net income: 126104000
Capital expenditures: 0
Operating cash flow: 213269000
Depreciation & amortization: 0
Net tangible assets: 2558919000
Owner earnings: 126104000
Return on net tangible assets (%): 4.928018432783531
Buffett classification: The Gruesome
Stock price: 11.26
P/E ratio: 7.468868256994227
Shares outstanding: 83646018
Book value: 2558919000
P/B ratio: 0.3680672044249935
Market cap (USD): 941854162.68
Debt to equity: 3.950499410102469
Effective tax rate (%): 0.08082024626404449
COGS to revenue (%): 0
SG&A to revenue (%): 27.19516721362713
Free cash flow (dilution-adjusted): 203717000
Buyback yield (%): 3.5144506773546262
Retained earnings: -1998055000
Receivables turnover: 2.6607068607068607
Capitalized R&D asset: 0
FCF margin (%): 99.48673620878262
Rule of 40 score: 99.48673620878262
Financial ratios for CIM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.85
Shares outstanding: 83646018
Market cap (USD): 1074851331.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIM — annual report dated 2024-12-31
Total revenue: 257929000
Net income: 176065000
Capital expenditures: 0
Operating cash flow: 205673000
Depreciation & amortization: 321000
Net tangible assets: 2526189000
Owner earnings: 176386000
Return on net tangible assets (%): 6.982296257326748
Buffett classification: The Gruesome
Stock price: 11.67
P/E ratio: 5.544253713458098
Shares outstanding: 83646018
Book value: 2526189000
P/B ratio: 0.38641171743681885
Market cap (USD): 976149030.06
Debt to equity: 3.964374399540177
Effective tax rate (%): 0.027822887447903063
COGS to revenue (%): 0
SG&A to revenue (%): 25.03208247230827
Free cash flow (dilution-adjusted): 195578000
Buyback yield (%): 0
Retained earnings: -2024957000
Receivables turnover: 3.1692060059469687
Capitalized R&D asset: 0
FCF margin (%): 75.82629328225985
Revenue growth (%): 25.961576027504297
Rule of 40 score: 101.78786930976415
Financial ratios for CIM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.67
Shares outstanding: 83646018
Market cap (USD): 976149030.06
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIM — quarterly report dated 2025-03-31
Total revenue: 196950000
Net income: 167297000
Capital expenditures: 0
Operating cash flow: 48799000
Depreciation & amortization: 951000
Net tangible assets: 2644064000
Owner earnings: 168248000
Return on net tangible assets (%): 6.363234777978143
Buffett classification: The Gruesome
Stock price: 11.01
P/E ratio: 1.3762091642109542
Shares outstanding: 83646018
Book value: 2644064000
P/B ratio: 0.348305736237852
Market cap (USD): 920942658.18
Debt to equity: 3.9322792489137934
Effective tax rate (%): 1.038142110119963
COGS to revenue (%): 0
SG&A to revenue (%): 10.150799695354152
Free cash flow (dilution-adjusted): 45056000
Buyback yield (%): 0
Retained earnings: -1909488000
Receivables turnover: 2.342356271259009
Capitalized R&D asset: 0
FCF margin (%): 22.876872302614874
Rule of 40 score: 22.876872302614874
Financial ratios for CIM — quarterly report dated 2025-06-30
Total revenue: 60082000
Net income: 35450000
Capital expenditures: 0
Operating cash flow: -7429000
Depreciation & amortization: 951000
Net tangible assets: 2624531000
Owner earnings: 36401000
Return on net tangible assets (%): 1.3869525640962137
Buffett classification: The Gruesome
Stock price: 12.22
P/E ratio: 5.041526335580798
Shares outstanding: 83646018
Book value: 2624531000
P/B ratio: 0.38946171333468727
Market cap (USD): 1022154339.96
Debt to equity: 4.472171218400545
Effective tax rate (%): 1.1405783764187514
COGS to revenue (%): 0
SG&A to revenue (%): 30.749642155720515
Free cash flow (dilution-adjusted): -9572000
Buyback yield (%): 0
Retained earnings: -1926170000
Receivables turnover: 0.8052700004020855
Capitalized R&D asset: 0
FCF margin (%): -15.931560201058554
Revenue growth (%): -69.4937801472455
Rule of 40 score: -85.42534034830406
Financial ratios for CIM — quarterly report dated 2025-09-30
Total revenue: 33829000
Net income: -580000
Capital expenditures: 0
Operating cash flow: -137477000
Depreciation & amortization: 948000
Net tangible assets: 2571238000
Owner earnings: 368000
Buffett classification: The Gruesome
Stock price: 11.97
P/E ratio: 4.95255326269866
Shares outstanding: 83646018
Book value: 2571238000
P/B ratio: 0.38940107273616836
Market cap (USD): 1001242835.46
Debt to equity: 4.751991842062073
COGS to revenue (%): 0
SG&A to revenue (%): 61.16645481687309
Free cash flow (dilution-adjusted): -177821000
Buyback yield (%): 0
Retained earnings: -1978925000
Receivables turnover: 0.113767903924991
Capitalized R&D asset: 0
FCF margin (%): -525.6466345443258
Revenue growth (%): -43.695283113078794
Rule of 40 score: -569.3419176574046
Financial ratios for CIM — annual report dated 2025-12-31
Total revenue: 356844000
Net income: 230499000
Capital expenditures: 38221000
Operating cash flow: -248879000
Depreciation & amortization: 7183000
Net tangible assets: 2572694000
Owner earnings: 199461000
Return on net tangible assets (%): 7.753001328568419
Buffett classification: The Gruesome
Stock price: 11.59
P/E ratio: 4.205906961071414
Shares outstanding: 83646018
Book value: 2572694000
P/B ratio: 0.37682575099098453
Market cap (USD): 969457348.62
Debt to equity: 5.080507436951304
Effective tax rate (%): 0.974364922862777
COGS to revenue (%): 0
SG&A to revenue (%): 24.2954904664223
Free cash flow (dilution-adjusted): -296794000
Buyback yield (%): 0
Retained earnings: -2003816000
Receivables turnover: 3.076639220588869
Capitalized R&D asset: 0
FCF margin (%): -83.17191826120097
Revenue growth (%): 38.349700886678114
Rule of 40 score: -44.82221737452286
Financial ratios for CIM — quarterly report dated 2025-12-31
Total revenue: 65982000
Net income: 28332000
Capital expenditures: 0
Operating cash flow: -152772000
Depreciation & amortization: 4333000
Net tangible assets: 2572694000
Owner earnings: 32665000
Return on net tangible assets (%): 1.2696807315599912
Buffett classification: The Gruesome
Stock price: 11.59
P/E ratio: 4.205906961071414
Shares outstanding: 83646018
Book value: 2572694000
P/B ratio: 0.37682575099098453
Market cap (USD): 969457348.62
Debt to equity: 5.080507436951304
Effective tax rate (%): -0.5251206358217428
COGS to revenue (%): 0
SG&A to revenue (%): 41.735624867388076
Free cash flow (dilution-adjusted): -154457000
Buyback yield (%): 0
Retained earnings: -2003816000
Receivables turnover: 0.5688839074018192
Capitalized R&D asset: 0
FCF margin (%): -234.0896001939923
Revenue growth (%): 95.0456708741021
Rule of 40 score: -139.0439293198902
Financial ratios for CKG.V — annual report dated 2021-12-31
Capital expenditures: 2674803.149606299
Buffett classification: The Gruesome
Stock price: 2.409448818897638
Shares outstanding: 76885609
Market cap (USD): 185251939.7952756
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CKG.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -6617.647058823529
Operating income: -3194852.9411764704
Net income: -7874999.999999999
Capital expenditures: 5147.058823529412
Operating cash flow: -3307352.9411764704
Depreciation & amortization: 6617.647058823529
Net tangible assets: 111007352.94117646
Owner earnings: -7873529.411764706
Return on net tangible assets (%): -7.09279989401868
Buffett classification: The Gruesome
Stock price: 1.389705882352941
Shares outstanding: 76885609
Book value: 112983823.52941175
P/B ratio: 0.9456962931314998
Market cap (USD): 106848383.0955882
Debt to equity: 0
Current ratio: 15.86275659824047
Quick ratio: 15.86275659824047
Interest coverage ratio: -1086.25
Free cash flow (dilution-adjusted): -4130147.0588235287
Buyback yield (%): 0
Retained earnings: -82361764.70588234
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.6669203668012913
Rule of 40 score: 0
Financial ratios for CKG.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -7575.757575757575
Operating income: -3253787.8787878784
Net income: -4291666.666666666
Capital expenditures: 129545.45454545454
Operating cash flow: -2318181.818181818
Depreciation & amortization: 7575.757575757575
Net tangible assets: 112915151.51515152
Owner earnings: -4413636.363636362
Return on net tangible assets (%): -3.908807900810476
Buffett classification: The Gruesome
Stock price: 1.3409090909090908
Shares outstanding: 76885609
Book value: 114724242.42424242
P/B ratio: 0.8986471376026836
Market cap (USD): 103096612.06818181
Debt to equity: 0
Current ratio: 12.094170403587444
Quick ratio: 12.094170403587444
Interest coverage ratio: -2147.5
Free cash flow (dilution-adjusted): -3047727.2727272725
Buyback yield (%): 0
Retained earnings: -89134090.9090909
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.642605319666029
Rule of 40 score: 0
Financial ratios for CKG.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.385185185185185
Shares outstanding: 76885609
Market cap (USD): 106500806.54074073
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CKG.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -10489.51048951049
Operating income: -2946153.8461538465
Net income: -1777622.3776223776
Capital expenditures: 26573.426573426575
Operating cash flow: -1644055.9440559442
Depreciation & amortization: 10489.51048951049
Net tangible assets: 102216783.21678323
Owner earnings: -1793706.2937062935
Return on net tangible assets (%): -1.7548060477526166
Buffett classification: The Gruesome
Stock price: 0.5944055944055944
Shares outstanding: 76885609
Book value: 103866433.56643356
P/B ratio: 0.44000005150509325
Market cap (USD): 45701236.118881114
Debt to equity: 0
Current ratio: 5.809569377990432
Quick ratio: 5.809569377990432
Interest coverage ratio: -4213
Free cash flow (dilution-adjusted): -2113986.013986014
Buyback yield (%): 0
Retained earnings: -84116783.21678323
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.6464731489449917
Rule of 40 score: 0
Financial ratios for CKG.V — quarterly report dated 2024-12-31
Capital expenditures: 65734.26573426573
Buffett classification: The Gruesome
Stock price: 0.5944055944055944
Shares outstanding: 76885609
Market cap (USD): 45701236.118881114
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CKG.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -2097.902097902098
Operating income: -511888.1118881119
Net income: -400699.3006993007
Capital expenditures: 0
Operating cash flow: -690209.7902097902
Depreciation & amortization: 2097.902097902098
Net tangible assets: 102325174.82517482
Owner earnings: -398601.3986013986
Return on net tangible assets (%): -0.38954382368016405
Buffett classification: The Gruesome
Stock price: 0.6993006993006994
Shares outstanding: 76885609
Book value: 103975524.47552449
P/B ratio: 0.5171040051114772
Market cap (USD): 53766160.139860146
Debt to equity: 0
Current ratio: 6.355134074558535
Quick ratio: 6.355134074558535
Free cash flow (dilution-adjusted): -745454.5454545454
Buyback yield (%): 0
Retained earnings: -84517482.51748252
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.45936905785414406
Rule of 40 score: 0
Financial ratios for CKG.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -2189.78102189781
Operating income: -772992.7007299269
Net income: -648905.109489051
Capital expenditures: 0
Operating cash flow: -632846.7153284671
Depreciation & amortization: 2189.78102189781
Net tangible assets: 109939416.05839415
Owner earnings: -646715.3284671532
Return on net tangible assets (%): -0.5882470106296102
Buffett classification: The Gruesome
Stock price: 1.0510948905109487
Shares outstanding: 76885609
Book value: 111648905.10948905
P/B ratio: 0.7238232268777907
Market cap (USD): 80814070.77372262
Debt to equity: 0
Current ratio: 8.238032786885245
Quick ratio: 8.238032786885245
Free cash flow (dilution-adjusted): -689051.0948905109
Buyback yield (%): 0
Retained earnings: -88867883.21167882
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6472472129865049
Rule of 40 score: 0
Financial ratios for CKG.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -2877.697841726619
Operating income: -712949.6402877698
Net income: -1259712.2302158275
Capital expenditures: 0
Operating cash flow: -828776.9784172663
Depreciation & amortization: 2877.697841726619
Net tangible assets: 107949640.2877698
Owner earnings: -1256834.5323741008
Return on net tangible assets (%): -1.1642785738087305
Buffett classification: The Gruesome
Stock price: 1.5539568345323742
Shares outstanding: 76885609
Book value: 109651079.13669066
P/B ratio: 1.089610047829938
Market cap (USD): 119476917.58273382
Debt to equity: 0
Current ratio: 7.75136612021858
Quick ratio: 7.75136612021858
Interest coverage ratio: -990.9999999999999
Free cash flow (dilution-adjusted): -883453.237410072
Buyback yield (%): 0
Retained earnings: -88859712.23021583
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6077219319547673
Rule of 40 score: 0
Financial ratios for CKG.V — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -9489.05109489051
Operating income: -3163503.6496350365
Net income: -3224817.518248175
Capital expenditures: 0
Operating cash flow: -3108029.197080292
Depreciation & amortization: 9489.05109489051
Net tangible assets: 109811678.83211678
Owner earnings: -3215328.4671532842
Return on net tangible assets (%): -2.9280387125935574
Buffett classification: The Gruesome
Stock price: 3.0291970802919708
Shares outstanding: 76885609
Book value: 112978102.18978101
P/B ratio: 2.061476142589482
Market cap (USD): 232901662.29927006
Debt to equity: 0
Current ratio: 6.625651720542231
Quick ratio: 6.625651720542231
Interest coverage ratio: -4334
Free cash flow (dilution-adjusted): -3421167.883211679
Buyback yield (%): 0
Retained earnings: -90150364.96350364
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.6120549893625356
Rule of 40 score: 0
Financial ratios for CKG.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -2189.78102189781
Operating income: -1132846.715328467
Net income: -868613.1386861313
Capital expenditures: 0
Operating cash flow: -928467.1532846715
Depreciation & amortization: 2189.78102189781
Net tangible assets: 109811678.83211678
Owner earnings: -866423.3576642335
Return on net tangible assets (%): -0.7890083886148815
Buffett classification: The Gruesome
Stock price: 3.0291970802919708
Shares outstanding: 76885609
Book value: 112978102.18978101
P/B ratio: 2.061476142589482
Market cap (USD): 232901662.29927006
Debt to equity: 0
Current ratio: 6.625651720542231
Quick ratio: 6.625651720542231
Free cash flow (dilution-adjusted): -1072262.7737226277
Buyback yield (%): 0
Retained earnings: -90150364.96350364
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.9353736371690483
Rule of 40 score: 0
Financial ratios for CLU.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7744360902255639
Shares outstanding: 416973515
Market cap (USD): 322919338.68421054
Buyback yield (%): 0.42147190417890995
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLU.AX — annual report dated 2022-06-30
Total revenue: 23630518.620689657
Gross profit: 12501028.27586207
Operating income: -15968547.586206896
Net income: -14411862.75862069
Capital expenditures: 150930.3448275862
Depreciation & amortization: 1196802.7586206896
Net tangible assets: 11495114.48275862
Owner earnings: -13365990.344827587
Return on net tangible assets (%): -116.2753999960163
Buffett classification: The Gruesome
Stock price: 0.3724137931034483
Shares outstanding: 416973515
Book value: 18407297.931034483
P/B ratio: 8.436147930382335
Market cap (USD): 155286688.3448276
Debt to equity: 0.02523384465726525
Current ratio: 2.8513479223153158
Quick ratio: 2.8513479223153158
Interest coverage ratio: -923.6633955640656
COGS to revenue (%): 47.09795211639233
SG&A to revenue (%): 115.41334975005438
Free cash flow (dilution-adjusted): -12114137.241379311
Buyback yield (%): 0.28447006156129956
Retained earnings: -22624008.275862068
Receivables turnover: 147.73850167079877
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -84.27975306023043
FCF margin (%): -51.264796324752695
Rule of 40 score: -51.264796324752695